Shilpa Medicare subsidiary's Karnataka facility clears GMP inspection 0 10.07.2024 08:09 Business Standard Shilpa Medicare said that ANVISA-Brazil successfully completed good manufacturing practice (GMP) inspection at its subsidiary, Shilpa Pharma Lifesciences' Active Pharmaceutical Ingredient (API) manufacturing facility, Unit II situated in Karnataka. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
